Jonathan Bye
Lawyers
Filters
IDEAYA Biosciences $143.8 million equity offering
The common stock is listed on the Nasdaq Global Select Market
RAPT Therapeutics $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Recursion Pharmaceuticals $300 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
IDEAYA Biosciences $250 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
IDEAYA Biosciences $201 million equity offering
The common stock is listed on the Nasdaq Global Select Market
AN2 Therapeutics $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Pacific Biosciences $201.25 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
TTX $300 million medium-term note offering
The investment-grade notes are due 2052
Recursion Pharmaceuticals $150 million private placement
We advised the placement agents on the private placement of common stock
IDEAYA Biosciences $92 million follow-on offering
The shares are listed on the Nasdaq Global Select Market